Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers

作者：Mark Daniel Pegram, Sheree Hsu, Gail Lewis, Richard J. Pietras, Malgorzata Beryt, Mark X. Sliwkowski, Daniel Coombs, D L Baly, Fairooz F. Kabbinavar, Dennis J. Slamon · 发表于：Oncogene · 年份：1999 · DOI：10.1038/sj.onc.1202526 · 被引用次数：694 · 研究领域：HER2/EGFR in Cancer Research、Monoclonal and Polyclonal Antibodies Research、Cancer Treatment and Pharmacology